Jennifer A. Johnson

发表

Extracting Asteroseismology from TESS FFIs: The TASOC Pipeline

Derek L. Buzasi, Lindsey Carboneau, Mikkel N. Lund, 2019 .

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Gordonia bronchialis Bacteremia and Pleural Infection: Case Report and Review of the Literature

Jennifer A. Johnson, F. Marty, A. Onderdonk, 2011, Journal of Clinical Microbiology.

Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System

Jennifer A. Johnson, S. Dryden-Peterson, L. Baden, 2022, Open forum infectious diseases.

Results of a Norovirus Outbreak Investigation in a Long Term Care Facility

Jennifer A. Johnson, S. Dhar, Christopher C Cooper, 2016 .

Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply.

Jennifer A. Johnson, J. Schnipper, R. Weiss, 2020, Journal of addiction medicine.

Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs.

Jennifer A. Johnson, J. Schnipper, R. Weiss, 2020, Journal of addiction medicine.

Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis

Jennifer A. Johnson, G. Corey, E. Feeney, 2015, Open forum infectious diseases.

CASE REPORTS Gordonia bronchialis Bacteremia and Pleural Infection: Case Report and Review of the Literature

Jennifer A. Johnson, F. Marty, A. Onderdonk, 2011 .

Antiretroviral therapy for treatment-naïve patients: A review of recent literature and the updated guidelines

Jennifer A. Johnson, P. Sax, 2009, Current infectious disease reports.

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States

Jennifer A. Johnson, D. Hooper, E. Hohmann, 2022, Open forum infectious diseases.

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Jennifer A. Johnson, J. Goudsmit, D. Barouch, 2013, The Journal of infectious diseases.

Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature

Jennifer A. Johnson, Margaret C Hayden, J. Suzuki, 2018, Open forum infectious diseases.

Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review

Jennifer A. Johnson, D. Kubiak, N. Beik, 2017, Open forum infectious diseases.

Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia.

Jennifer A. Johnson, D. Musher, B. Dang, 2015, The Permanente journal.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

Jennifer A. Johnson, B. Korber, P. Earl, 2018, The Journal of infectious diseases.

Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.

Jennifer A. Johnson, D. Milner, D. Barouch, 2015, The Journal of infectious diseases.

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).

Jennifer A. Johnson, D. Barouch, M. Seaman, 2014, The Journal of infectious diseases.

Feasibility and Safety of Outpatient Parenteral Antimicrobial Therapy in Conjunction With Addiction Treatment for People Who Inject Drugs.

Jennifer A. Johnson, J. Suzuki, Mary W. Montgomery, 2020, The Journal of infectious diseases.

Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis.

Jennifer A. Johnson, J. Schnipper, R. Weiss, 2020, The American journal on addictions.

Nonreplicating vectors in HIV vaccines.

Jennifer A. Johnson, D. Barouch, L. Baden, 2013, Current opinion in HIV and AIDS.

Beginning antiretroviral therapy for patients with HIV.

Jennifer A. Johnson, P. Sax, 2014, Infectious disease clinics of North America.

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment*

Joshua A. Doherty, Jennifer A. Johnson, Garrett E. Schramm, 2006, Critical care medicine.

Increasing Incidence of Sterile-Site Infections Due to Non-Multidrug-Resistant, Oxacillin-Resistant Staphylococcus aureus Among Hospitalized Patients

Joshua A. Doherty, Jennifer A. Johnson, Garrett E. Schramm, 2007, Infection Control & Hospital Epidemiology.

HIV-2 encephalitis: case report and literature review.

Jennifer A. Johnson, Brian R Wood, R. Folkerth, 2012, AIDS patient care and STDs.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.